Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Differentiating type 1 and 2 acute myocardial infarctions using the N-terminal pro B-type natriuretic peptide/cardiac troponin T ratio.

Nowak RM, Jacobsen G, Christenson RH, Moyer M, Hudson M, McCord J.

Am J Emerg Med. 2018 Jul 2. pii: S0735-6757(18)30555-2. doi: 10.1016/j.ajem.2018.06.073. [Epub ahead of print]

PMID:
30007549
2.

Corrigendum to 'Validation of high-sensitivity performance for a United States Food and Drug Administration cleared cardiac troponin I assay' [Clin. Biochem. 56 (2018) 4-10].

Christenson RH, Mullins K, Duh SH.

Clin Biochem. 2018 Aug;58:132. doi: 10.1016/j.clinbiochem.2018.06.008. No abstract available.

PMID:
29908760
3.

Validation of high-sensitivity performance for a United States Food and Drug Administration cleared cardiac troponin I assay.

Christenson RH, Mullins K, Duh SH.

Clin Biochem. 2018 Jun;56:4-10. doi: 10.1016/j.clinbiochem.2018.05.004. Epub 2018 May 9. Erratum in: Clin Biochem. 2018 Aug;58:132.

PMID:
29750939
4.

Copeptin to rule out myocardial infarction in Blacks versus Caucasians.

Beri N, Daniels LB, Jaffe A, Mueller C, Anand I, Peacock WF, Hollander JE, DeFilippi C, Schreiber D, McCord J, Limkakeng AT, Wu AHB, Apple FS, Diercks DB, Nagurney JT, Nowak RM, Cannon CM, Clopton P, Neath SX, Christenson RH, Hogan C, Vilke G, Maisel A.

Eur Heart J Acute Cardiovasc Care. 2018 May 1:2048872618772500. doi: 10.1177/2048872618772500. [Epub ahead of print]

PMID:
29737180
5.

N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study.

Januzzi JL Jr, Chen-Tournoux AA, Christenson RH, Doros G, Hollander JE, Levy PD, Nagurney JT, Nowak RM, Pang PS, Patel D, Peacock WF, Rivers EJ, Walters EL, Gaggin HK; ICON-RELOADED Investigators.

J Am Coll Cardiol. 2018 Mar 20;71(11):1191-1200. doi: 10.1016/j.jacc.2018.01.021.

6.

"Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).

Peters MN, Seliger SL, Christenson RH, Hong-Zohlman SN, Daniels LB, Lima JAC, de Lemos JA, Neeland IJ, deFilippi CR.

J Am Heart Assoc. 2018 Feb 8;7(4). pii: e006619. doi: 10.1161/JAHA.117.006619.

7.

Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.

Mindikoglu AL, Opekun AR, Mitch WE, Magder LS, Christenson RH, Dowling TC, Weir MR, Seliger SL, Howell CD, Raufman JP, Rana A, Goss JA, Khaderi SA, Vierling JM.

Dig Dis Sci. 2018 Mar;63(3):665-675. doi: 10.1007/s10620-017-4897-z. Epub 2018 Feb 1.

PMID:
29392554
9.

Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis.

Mindikoglu AL, Opekun AR, Putluri N, Devaraj S, Sheikh-Hamad D, Vierling JM, Goss JA, Rana A, Sood GK, Jalal PK, Inker LA, Mohney RP, Tighiouart H, Christenson RH, Dowling TC, Weir MR, Seliger SL, Hutson WR, Howell CD, Raufman JP, Magder LS, Coarfa C.

Transl Res. 2018 May;195:25-47. doi: 10.1016/j.trsl.2017.12.002. Epub 2017 Dec 12.

PMID:
29291380
10.

Trends in Use of Biomarker Protocols for the Evaluation of Possible Myocardial Infarction.

Hachey BJ, Kontos MC, Newby LK, Christenson RH, Peacock WF, Brewer KC, McCord J.

J Am Heart Assoc. 2017 Sep 22;6(9). pii: e005852. doi: 10.1161/JAHA.117.005852.

11.

Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.

Gaggin HK, Chen-Tournoux AA, Christenson RH, Doros G, Hollander JE, Levy PD, Nagurney JT, Nowak RM, Pang PS, Patel D, Peacock WF, Walters EL, Januzzi JL; ICON-RELOADED Investigators.

Am Heart J. 2017 Oct;192:26-37. doi: 10.1016/j.ahj.2017.07.002. Epub 2017 Jul 8.

PMID:
28938961
12.
13.

Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial.

Juraschek SP, Miller ER 3rd, Appel LJ, Christenson RH, Sacks FM, Selvin E.

Diabet Med. 2017 Oct;34(10):1407-1413. doi: 10.1111/dme.13391. Epub 2017 Jul 9.

15.

Total Analytic Error for Low Cardiac Troponin Concentrations (≤10 ng/L) by Use of a High-Sensitivity Cardiac Troponin Assay.

Kavsak PA, Jaffe AS, Greene DN, Christenson RH, Apple FS, Wu AHB.

Clin Chem. 2017 May;63(5):1043-1045. doi: 10.1373/clinchem.2017.271361. Epub 2017 Mar 21. No abstract available.

16.

Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort.

Loomis SJ, Chen Y, Sacks DB, Christenson ES, Christenson RH, Rebholz CM, Selvin E.

Clin Chem. 2017 May;63(5):980-989. doi: 10.1373/clinchem.2016.264135. Epub 2017 Mar 9.

17.

Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department.

McCord J, Cabrera R, Lindahl B, Giannitsis E, Evans K, Nowak R, Frisoli T, Body R, Christ M, deFilippi CR, Christenson RH, Jacobsen G, Alquezar A, Panteghini M, Melki D, Plebani M, Verschuren F, French J, Bendig G, Weiser S, Mueller C; TRAPID-AMI Investigators.

Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2). pii: e003101. doi: 10.1161/CIRCOUTCOMES.116.003101.

18.

High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis).

Seliger SL, Hong SN, Christenson RH, Kronmal R, Daniels LB, Lima JAC, de Lemos JA, Bertoni A, deFilippi CR.

Circulation. 2017 Apr 18;135(16):1494-1505. doi: 10.1161/CIRCULATIONAHA.116.025505. Epub 2017 Feb 3.

19.

Effect of type and amount of dietary carbohydrate on biomarkers of glucose homeostasis and C reactive protein in overweight or obese adults: results from the OmniCarb trial.

Juraschek SP, Miller ER 3rd, Selvin E, Carey VJ, Appel LJ, Christenson RH, Sacks FM.

BMJ Open Diabetes Res Care. 2016 Nov 14;4(1):e000276. eCollection 2016.

20.

Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation.

Mueller-Hennessen M, Mueller C, Giannitsis E, Biener M, Vafaie M, deFilippi CR, Christ M, Ordóñez-Llanos J, Panteghini M, Plebani M, Verschuren F, Melki D, French JK, Christenson RH, Body R, McCord J, Dinkel C, Katus HA, Lindahl B; TRAPID-AMI Investigators.

Clin Chem. 2017 Feb;63(2):542-551. doi: 10.1373/clinchem.2016.258392. Epub 2016 Dec 8.

21.

Cardiorespiratory Fitness and Highly Sensitive Cardiac Troponin Levels in a Preventive Medicine Cohort.

DeFina LF, Willis BL, Radford NB, Christenson RH, deFilippi CR, de Lemos JA.

J Am Heart Assoc. 2016 Nov 28;5(12). pii: e003781.

22.

Necessity of hospitalization and stress testing in low risk chest pain patients.

Beri N, Marston NA, Daniels LB, Nowak RM, Schreiber D, Mueller C, Jaffe A, Diercks DB, Wettersten N, DeFilippi C, Peacock WF, Limkakeng AT, Anand I, McCord J, Hollander JE, Wu AHB, Apple FS, Nagurney JT, Berardi C, Cannon CM, Clopton P, Neath SX, Christenson RH, Hogan C, Vilke G, Maisel A.

Am J Emerg Med. 2017 Feb;35(2):274-280. doi: 10.1016/j.ajem.2016.10.072. Epub 2016 Oct 29.

PMID:
27847253
23.

Lipoprotein Biomarkers and Risk of Cardiovascular Disease: A Laboratory Medicine Best Practices (LMBP) Systematic Review.

Sandhu PK, Musaad SM, Remaley AT, Buehler SS, Strider S, Derzon JH, Vesper HW, Ranne A, Shaw CS, Christenson RH.

J Appl Lab Med. 2016 Sep 1;1(2):214-229. Epub 2016 Aug 1.

24.

Multicenter evaluation of analytical characteristics of the Elecsys® Periostin immunoassay.

Palme S, Christenson RH, Jortani SA, Ostlund RE, Kolm R, Kopal G, Laubender RP.

Clin Biochem. 2017 Feb;50(3):139-144. doi: 10.1016/j.clinbiochem.2016.10.002. Epub 2016 Oct 8.

25.

Defining the Path Forward: Guidance for Laboratory Medicine Guidelines.

Kahn SE, Jones PM, Chin AC, Christenson RH.

EJIFCC. 2015 Aug 24;26(3):158-67. eCollection 2015 Aug.

26.

Impact of moderate physical activity on the longitudinal trajectory of a cardiac specific biomarker of injury: Results from a randomized pilot study of exercise intervention.

deFilippi CR, de Lemos JA, Newman AB, Guralnik JM, Christenson RH, Pahor M, Church T, Espeland M, Krithevsky SB, Stafford R, Seliger SL; LIFE Study Group.

Am Heart J. 2016 Sep;179:151-6. doi: 10.1016/j.ahj.2016.07.001. Epub 2016 Jul 12.

PMID:
27595690
27.

How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE).

Collinson P, Hammerer-Lercher A, Suvisaari J, Apple FS, Christenson RH, Pulkki K, van Dieijen-Visser MP, Duff CJ, Baum H, Stavljenic-Rukavina A, Aakre KM, Langlois MR, Stankovic S, Laitinen P; Working Group for Cardiac Markers, European Federation of Clinical Chemistry and Laboratory Medicine.

Clin Chem. 2016 Sep;62(9):1264-71. doi: 10.1373/clinchem.2016.259515. Epub 2016 Jul 26.

28.

Galectin-3 and Risk of Heart Failure and Death in Blacks and Whites.

McEvoy JW, Chen Y, Halushka MK, Christenson E, Ballantyne CM, Blumenthal RS, Christenson RH, Selvin E.

J Am Heart Assoc. 2016 May 13;5(5). pii: e003079. doi: 10.1161/JAHA.115.003079.

29.

The standards for reporting diagnostic accuracy studies 2015 update: is there a missing link to the triumvirate?

Wu AH, Christenson RH.

Ann Transl Med. 2016 Feb;4(3):44. doi: 10.3978/j.issn.2305-5839.2015.12.41. No abstract available.

30.

Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T - Sub-analysis from the TRAPID-AMI study.

Mueller-Hennessen M, Lindahl B, Giannitsis E, Biener M, Vafaie M, deFilippi CR, Christ M, Santalo-Bel M, Panteghini M, Plebani M, Verschuren F, Jernberg T, French JK, Christenson RH, Body R, McCord J, Dilba P, Katus HA, Mueller C; TRAPID-AMI Investigators.

Int J Cardiol. 2016 Apr 15;209:26-33. doi: 10.1016/j.ijcard.2016.01.213. Epub 2016 Feb 3.

PMID:
26878470
31.

Critical appraisal in the practice of laboratory medicine.

Price CP, Christenson RH.

Ann Clin Biochem. 2016 Mar;53(Pt 2):222-32. doi: 10.1177/0004563215599008. Epub 2015 Jul 17. Review.

PMID:
26187554
32.

Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study.

Beatty AL, Ku IA, Bibbins-Domingo K, Christenson RH, DeFilippi CR, Ganz P, Ix JH, Lloyd-Jones D, Omland T, Sabatine MS, Schiller NB, Shlipak MG, Skali H, Takeuchi M, Vittinghoff E, Whooley MA.

J Am Heart Assoc. 2015 Jul 6;4(7). pii: e001646. doi: 10.1161/JAHA.114.001646.

33.

Pharmacokinetics and Tolerability of Intravenous Sildenafil in Two Subjects with Child-Turcotte-Pugh Class C Cirrhosis and Renal Dysfunction.

Mindikoglu AL, Dowling TC, Schaub DJ, Hutson WR, Potosky DR, Christenson RH, Barth RN, LaMattina JC, Hanish SI, Weir MR, Raufman JP.

Dig Dis Sci. 2015 Nov;60(11):3491-4. doi: 10.1007/s10620-015-3771-0. Epub 2015 Jul 5. No abstract available.

34.

Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines.

Mindikoglu AL, Dowling TC, Magder LS, Christenson RH, Weir MR, Seliger SL, Hutson WR, Howell CD.

Clin Gastroenterol Hepatol. 2016 Apr;14(4):624-632.e2. doi: 10.1016/j.cgh.2015.06.021. Epub 2015 Jun 29.

35.

Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trial.

Marston NA, Shah KS, Mueller C, Neath SX, Christenson RH, McCord J, Nowak RM, Daniels LB, Hollander JE, Apple F, Nagurney J, Schreiber D, deFilippi C, Diercks D, Limkakeng A, Anand IS, Wu AH, Jaffe AS, Peacock WF, Maisel AS.

Emerg Med J. 2016 Jan;33(1):23-9. doi: 10.1136/emermed-2015-204692. Epub 2015 Jun 23.

PMID:
26105583
36.

Evaluation of standardization capability of current cardiac troponin I assays by a correlation study: results of an IFCC pilot project.

Tate JR, Bunk DM, Christenson RH, Barth JH, Katrukha A, Noble JE, Schimmel H, Wang L, Panteghini M; IFCC Working Group on Standardization of Cardiac Troponin I.

Clin Chem Lab Med. 2015 Apr;53(5):677-90. doi: 10.1515/cclm-2014-1197.

37.

Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial.

Shah KS, Marston NA, Mueller C, Neath SX, Christenson RH, McCord J, Nowak RM, Vilke GM, Daniels LB, Hollander JE, Apple FS, Cannon CM, Nagurney J, Schreiber D, deFilippi C, Hogan CJ, Diercks DB, Limkakeng A, Anand IS, Wu AH, Clopton P, Jaffe AS, Peacock WF, Maisel AS.

Acad Emerg Med. 2015 May;22(5):554-63. doi: 10.1111/acem.12649. Epub 2015 Apr 23.

38.

Evolving role of galectin-3 as a cardiac biomarker: heart failure with preserved ejection fraction and renal function, important pieces of the puzzle.

deFilippi CR, Christenson RH.

JACC Heart Fail. 2015 Mar;3(3):253-6. doi: 10.1016/j.jchf.2014.12.009. No abstract available.

39.

Effectiveness of practices for improving the diagnostic accuracy of Non ST Elevation Myocardial Infarction in the Emergency Department: A Laboratory Medicine Best Practices™ systematic review.

Layfield C, Rose J, Alford A, Snyder SR, Apple FS, Chowdhury FM, Kontos MC, Newby LK, Storrow AB, Tanasijevic M, Leibach E, Liebow EB, Christenson RH.

Clin Biochem. 2015 Mar;48(4-5):204-12. doi: 10.1016/j.clinbiochem.2015.01.014. Epub 2015 Feb 7. Review.

40.

Prognostic significance of active and modified forms of endothelin 1 in patients with heart failure with reduced ejection fraction.

Gottlieb SS, Harris K, Todd J, Estis J, Christenson RH, Torres V, Whittaker K, Rebuck H, Wawrzyniak A, Krantz DS.

Clin Biochem. 2015 Mar;48(4-5):292-6. doi: 10.1016/j.clinbiochem.2014.12.012. Epub 2014 Dec 23.

41.

Cardiac biomarkers - A short biography.

Collinson PO, Garrison L, Christenson RH.

Clin Biochem. 2015 Mar;48(4-5):197-200. doi: 10.1016/j.clinbiochem.2014.11.014. Epub 2014 Nov 22. No abstract available.

PMID:
25464015
42.

High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.

Bansal N, Hyre Anderson A, Yang W, Christenson RH, deFilippi CR, Deo R, Dries DL, Go AS, He J, Kusek JW, Lash JP, Raj D, Rosas S, Wolf M, Zhang X, Shlipak MG, Feldman HI.

J Am Soc Nephrol. 2015 Apr;26(4):946-56. doi: 10.1681/ASN.2014010108. Epub 2014 Oct 2. Erratum in: J Am Soc Nephrol. 2015 Oct;26(10):2599.

43.

Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.

Bagai A, Schulte PJ, Granger CB, Mahaffey KW, Christenson RH, Bell G, Lopes RD, Green CL, Lincoff AM, Armstrong PW, Roe MT.

Am Heart J. 2014 Oct;168(4):503-511.e2. doi: 10.1016/j.ahj.2014.06.008. Epub 2014 Jun 9.

PMID:
25262260
44.

Absolute and relative changes (delta) in troponin I for early diagnosis of myocardial infarction: Results of a prospective multicenter trial.

Storrow AB, Nowak RM, Diercks DB, Singer AJ, Wu AH, Kulstad E, LoVecchio F, Fromm C, Headden G, Potis T, Hogan CJ, Schrock JW, Zelinski DP, Greenberg MR, Christenson RH, Ritchie JC, Chamberlin JS, Bray KR, Rhodes DW, Trainor D, Southwick PC.

Clin Biochem. 2015 Mar;48(4-5):260-7. doi: 10.1016/j.clinbiochem.2014.09.012. Epub 2014 Sep 28.

PMID:
25261587
45.

Diagnostic performance of cardiac Troponin I for early rule-in and rule-out of acute myocardial infarction: Results of a prospective multicenter trial.

Storrow AB, Christenson RH, Nowak RM, Diercks DB, Singer AJ, Wu AH, Kulstad E, LoVecchio F, Fromm C, Headden G, Potis T, Hogan CJ, Schrock JW, Zelinski DP, Greenberg MR, Ritchie JC, Chamberlin JS, Bray KR, Rhodes DW, Trainor D, Holmes D, Southwick PC.

Clin Biochem. 2015 Mar;48(4-5):254-9. doi: 10.1016/j.clinbiochem.2014.08.018. Epub 2014 Sep 4.

PMID:
25195101
46.

Harmonized laboratory results are in tune with effective healthcare goals.

Christenson RH, Kassed CA.

J Comp Eff Res. 2014 May;3(3):221-4. doi: 10.2217/cer.14.11. No abstract available.

PMID:
24969146
47.

A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements.

Mindikoglu AL, Dowling TC, Wong-You-Cheong JJ, Christenson RH, Magder LS, Hutson WR, Seliger SL, Weir MR.

Am J Nephrol. 2014;39(6):543-52. doi: 10.1159/000363584. Epub 2014 Jun 17.

48.

Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.

Shafi T, Zager PG, Sozio SM, Grams ME, Jaar BG, Christenson RH, Boulware LE, Parekh RS, Powe NR, Coresh J.

Am J Kidney Dis. 2014 Sep;64(3):443-51. doi: 10.1053/j.ajkd.2014.03.015. Epub 2014 Apr 29.

49.

Reference interval evaluation of high-sensitivity troponin T and N-terminal B-type natriuretic peptide in Vietnam and the US: The North South East West Trial.

Gaggin HK, Dang PV, Do LD, deFilippi CR, Christenson RH, Lewandrowski EL, Lewandrowski KB, Truong BQ, Pham VQ, Vu VH, Vu TV, Nguyen TB, Belcher AM, Femia A, Kelley C, Januzzi JL.

Clin Chem. 2014 May;60(5):758-64. doi: 10.1373/clinchem.2013.216275. Epub 2014 Feb 25.

50.

Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay.

Gore MO, Seliger SL, Defilippi CR, Nambi V, Christenson RH, Hashim IA, Hoogeveen RC, Ayers CR, Sun W, McGuire DK, Ballantyne CM, de Lemos JA.

J Am Coll Cardiol. 2014 Apr 15;63(14):1441-8. doi: 10.1016/j.jacc.2013.12.032. Epub 2014 Feb 12.

Supplemental Content

Loading ...
Support Center